Big Pharma's Commedia
Copyright policy )Big Pharma's Commedia
Despite continuing financial success, many big pharmaceutical companies are facing an uncertain future. Merging basic and clinical research in a determined effort to fully elucidate the molecular mechanisms of disease and thus to develop effective drugs with fewer side effects is the tough journey ahead that big pharma needs to pursue to ensure a brighter future.
- Massachusetts Institute of Technology United States
- Broad Institute United States
- Rowland Institute at Harvard United States
Marketing, Clinical Trials as Topic, Biomedical Research, Drug Industry, Biochemistry, Genetics and Molecular Biology(all), United States Food and Drug Administration, United States, Drug Therapy, Humans, Forecasting
Marketing, Clinical Trials as Topic, Biomedical Research, Drug Industry, Biochemistry, Genetics and Molecular Biology(all), United States Food and Drug Administration, United States, Drug Therapy, Humans, Forecasting
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).3 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!